Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241420 · ClinicalTrials.gov registry record
Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease
A clinical trial of Chronic Lung Disease, sponsored by National Jewish Health.
- Active
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT03241420: Active study of Chronic Lung Disease, sponsored by National Jewish Health.
NCT03241420 is a study of Chronic Lung Disease that is active but no longer recruiting, run by National Jewish Health. The registered enrollment target is 600 participants, above the 291-participant average among 9 other Chronic Lung Disease trials with a reported enrollment target (106% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03241420, a study of Chronic Lung Disease, is active but no longer recruiting, sponsored by National Jewish Health.
- ACTIVE NOT RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of small airways disease in adults with chronic lung conditions compared to healthy adults, adjusting for age, sex and smoking status.
Primary Outcome
Average of three acceptable trials.
Conditions Studied
Interventions
- DEVICE lung clearance index (LCI)
Study Locations (1)
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2025-12 |
What the registry record for NCT03241420 still lists
NCT03241420 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 291-participant average among 9 other Chronic Lung Disease trials with a reported enrollment target (106% higher).
The record links to 1 condition, with Chronic Lung Disease appearing as the primary indexed condition, and to 1 intervention - of which lung clearance index (LCI) is the first listed.
NCT03241420 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT03241420 about?
NCT03241420 is a clinical study titled "Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease". To determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of small airways disease in adults with chronic lung conditions compared to healthy adults, adjusting for age, sex and smoking status.
What is the current status of trial NCT03241420?
This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2017-04-24. Estimated completion is 2025-12.
What conditions does trial NCT03241420 study?
This clinical trial studies the following conditions: Chronic Lung Disease.
What interventions are being tested in trial NCT03241420?
The interventions under investigation include: lung clearance index (LCI) (DEVICE).
Who is sponsoring clinical trial NCT03241420?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03241420 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Lung Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03241420's enrollment target sits among peer trials
600 2nd of 9 the highest of 9 other Chronic Lung Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Lung Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
-
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
RECRUITING
-
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
RECRUITING
-
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI